Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1985;85(4):464-8.
doi: 10.1007/BF00429666.

Locomotor effects of lisuride: a consequence of dopaminergic and serotonergic actions

Comparative Study

Locomotor effects of lisuride: a consequence of dopaminergic and serotonergic actions

H Fink et al. Psychopharmacology (Berl). 1985.

Abstract

The open-field test was used to study the involvement of serotonergic and dopaminergic mechanisms in the action of lisuride on locomotor activity in the rat. Lisuride produced a biphasic locomotor effect. The maximum locomotor stimulatory response of lisuride was stronger than that of apomorphine and comparable with that of apomorphine and LSD combined. Hypermotility induced by high doses of lisuride was partially suppressed by the serotonin antagonist cyproheptadine and not further enhanced by LSD. A moderate dose of lisuride potentiated apomorphine-induced hypermotility in the same manner as has been shown for LSD. Lesion of dopaminergic structures within the median raphe nucleus by 6-OHDA produced a potentiation of lisuride-induced hypermotility. This effect was suppressed by cyproheptadine. The locomotor inhibitory effect of low doses of lisuride may be related to a stimulation of presynaptic mesolimbic dopamine receptors. It is concluded that the locomotor stimulant effect of higher doses of lisuride may depend on stimulation of postsynaptic dopamine receptors and a serotonergic action and that the locomotor effects of lisuride reflect a complex interaction at dopaminergic and serotonergic transmission systems.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Psychopharmacology (Berl). 1981;73(4):328-31 - PubMed
    1. Nature. 1978 Mar 16;272(5650):278-80 - PubMed
    1. Acta Biol Med Ger. 1980;39(8-9):917-21 - PubMed
    1. J Hirnforsch. 1984;25(3):343-9 - PubMed
    1. Psychopharmacology (Berl). 1979 Nov;65(3):233-7 - PubMed

Publication types

LinkOut - more resources